Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.
Published September 25, 2019 · Recall initiated: September 6, 2019
Summary
FDA records drug Class II recall D-1862-2019, published September 25, 2019 and initiated September 6, 2019. Recalling firm: Torrent Pharma Inc.; Status: Terminated; Reported quantity: 2472 bottles; Lot: Lot #: BFE2E003, Exp 08/31/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if ANAGRELIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ANAGRELIDE
- Manufacturer
- Torrent Pharma Inc.
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot #: BFE2E003, Exp 08/31/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAnagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., BaskingDecember 9, 2020
- FDASuperior Pain & Itch Relief (lidocaine) Liquid Gel, 4%, packaged in a) 1 Oz (NDC 69804-073-14), b) 2 Oz (NDCSeptember 25, 2019
- FDAOxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-WardSeptember 25, 2019
- FDAPRE-TAT (lidocaine) 3 in 1 Pre Tattoo Prep With Lidocaine Liquid Gel, 4%, packaged in a) 1 Oz (NDCSeptember 25, 2019
- FDAAllergy Relief (fexofenadine hydrochrloride) tablets, 180 mg, 5-count carton, Good Neighbor Pharmacy,September 25, 2019
- FDAPRE-TAT (lidocaine) 3 in 1 Pre Tattoo Prep With Lidocaine Cream, 4%, packaged in a) 1 OZ (NDC 69804-002-05),September 25, 2019
Questions about this recall
Was Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01. recalled?
Yes. FDA published recall D-1862-2019 on September 25, 2019. Reported hazard: Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ANAGRELIDE.